Dr. Francis Collins (NIH) Speaks About the Cancer Funding Predicament We Face
A post from Alan on the Advanced Prostate Cancer On-Line Support Group shared a link, which should interest all of us. It should interest us all because it will have an effect on each and [...]
Yervoy (ipilimumab) Fails to Extend Survival in Men with mCRP Who Failed Chemo
Some bad news was reported today. Results from the Phase 3 randomized, double-blind clinical trial (Study 043) comparing Yervoy 10 mg/kg (ipilimumab) (n=399) to placebo (n=400) following radiation in men with advanced metastatic castration-resistant prostate [...]
Living Through Chemo with the Support of Natural Immune System Boosts – Probiotics
Mama might have been correct, eat your yogurt. Many of us already know that a healthy gut with plenty of probiotics to support your gastrointestinal health is absolutely critical to boosting your immune system. Experts [...]
Perineural Invasion – Is It An Accurate Predictor of Extra-Prostatic Extension of Prostate Cancer?
Many clinicians are concerned when a patient comes to them with prostate cancer that has been shown to have perineural invasion (PNI). PNI is defined as the presence of prostate cancer found by biopsy that [...]
Who will respond to Zytiga (Abiraterone) and Xtandi (Enzalutamide)?
We have many new drugs that have been recently approved to treat advanced prostate cancer. Two of these drugs are abiraterone (Zytiga) and enzalutamide (Xtandi). These drugs offer new hope to men with advanced prostate [...]
Metastasis-Free Survival Is A Possible Biomarker for Overall Survival
Researchers at Johns Hopkins has concluded that metastasis-free survival appeared to independently predictor of overall survival (OS) in men with recurrent prostate cancer who underwent androgen deprivation therapy (ADT) after developing metastases. Men with biochemically [...]